Evidence map›Paper›PMID 36449357›Full record

ReviewAnnual review of genetics2022

Quiescence in

Linda L Breeden, Toshio Tsukiyama

Abstract readReview
In one paragraph

Review in Annual review of genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. RiboCop surveils pre-rRNA processing by Dicer in cellular quiescence.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Stage-specific MCM protein expression inFrontiers in cellular and infection microbiology · 2025
    Article
  15. Article
  16. Article
  17. Interactions ofFoods (Basel, Switzerland) · 2024
    Article
  18. Article
  19. Article
  20. Microbial life in slow and stopped lanes.Trends in microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Linda L BreedenBasic Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA; email: lbreeden@fredhutch.org, ttsukiya@fredhutch.org.
Toshio TsukiyamaBasic Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA; email: lbreeden@fredhutch.org, ttsukiya@fredhutch.org.

Funding

Molecular mechanisms and functions of global chromatin controlR35GM139429 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOSHIO TSUKIYAMA · 2021 to 2026
$4.6M
Mechanisms and functions of chromatin regulation for cell-cycle controlR01GM111428 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TSUKIYAMA, TOSHIO · 2015 to 2020
$2.4M
Cell Cycle Re-entry from quiescenceR01GM120318 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BREEDEN, LINDA L. · 2017 to 2020
$1.8M
NIGMS NIH HHS R01 GM111428NIGMS NIH HHS R01 GM120318NIGMS NIH HHS R35 GM139429
6 · The paper itself

Abstract

Most cells live in environments that are permissive for proliferation only a small fraction of the time. Entering quiescence enables cells to survive long periods of nondivision and reenter the cell cycle when signaled to do so. Here, we describe what is known about the molecular basis for quiescence in

Indexed as

Protein Processing, Post-TranslationalSaccharomyces cerevisiaeCell CycleChromatinCytoplasmChromatinG0PKAquiescenceSaccharomyces cerevisiaeTorc1

Identifiers

PMID36449357
PMCPMC11694697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.